Skip to content

Clinical trials

Non-ST Elevated Myocardial Infarction trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Non-ST Elevated Myocardial Infarction Country / region: Canada Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20093
20111
20121
20142
20161
20181
20191
20212
20221
20231
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Active, not recruiting2
Recruiting2
Unknown status2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline3
Novartis Pharmaceuticals2
Population Health Research Institute2
Abiomed Inc.1
Biotronik Canada Inc1
Centre hospitalier de l'Université de Montréal (CHUM)1
Cogentus Pharmaceuticals1
Eli Lilly and Company1
Montreal Heart Institute1
Ottawa Heart Institute Research Corporation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Non-ST Elevated Myocardial Infarction18
ST Elevation Myocardial Infarction10
Acute Coronary Syndrome8
Coronary Artery Disease6
Myocardial Infarction5
Angina, Unstable3
Myocardial Ischemia3
Cardiovascular Diseases2
Coronary Stenosis2
Heart Diseases2

Trials

Showing 51 to 18 of 18. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.